359 related articles for article (PubMed ID: 26076035)
1. Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion.
van der Meulen T; Donaldson CJ; Cáceres E; Hunter AE; Cowing-Zitron C; Pound LD; Adams MW; Zembrzycki A; Grove KL; Huising MO
Nat Med; 2015 Jul; 21(7):769-76. PubMed ID: 26076035
[TBL] [Abstract][Full Text] [Related]
2. Urocortin3: Local inducer of somatostatin release and bellwether of beta cell maturity.
Flisher MF; Shin D; Huising MO
Peptides; 2022 May; 151():170748. PubMed ID: 35065098
[TBL] [Abstract][Full Text] [Related]
3. Urocortin 3 contributes to paracrine inhibition of islet alpha cells in mice.
Noguchi GM; Castillo VC; Donaldson CJ; Flisher MR; Momen AT; Saghatelian A; Huising MO
J Endocrinol; 2024 Jun; 261(3):. PubMed ID: 38593829
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats.
Grunddal KV; Trammell SAJ; Bæch-Laursen C; Andersen DB; Xu SFS; Andersen H; Gillum MP; Ghiasi SM; Novak I; Tyrberg B; Li C; Rosenkilde MM; Hartmann B; Holst JJ; Kuhre RE
Diabetologia; 2022 Jun; 65(6):1018-1031. PubMed ID: 35325259
[TBL] [Abstract][Full Text] [Related]
5. The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.
Li XN; Herrington J; Petrov A; Ge L; Eiermann G; Xiong Y; Jensen MV; Hohmeier HE; Newgard CB; Garcia ML; Wagner M; Zhang BB; Thornberry NA; Howard AD; Kaczorowski GJ; Zhou YP
J Pharmacol Exp Ther; 2013 Feb; 344(2):407-16. PubMed ID: 23161216
[TBL] [Abstract][Full Text] [Related]
6. A cullin 4B-RING E3 ligase complex fine-tunes pancreatic δ cell paracrine interactions.
Li Q; Cui M; Yang F; Li N; Jiang B; Yu Z; Zhang D; Wang Y; Zhu X; Hu H; Li PS; Ning SL; Wang S; Qi H; Song H; He D; Lin A; Zhang J; Liu F; Zhao J; Gao L; Yi F; Xue T; Sun JP; Gong Y; Yu X
J Clin Invest; 2017 Jun; 127(7):2631-2646. PubMed ID: 28604389
[TBL] [Abstract][Full Text] [Related]
7. The somatostatin receptor in human pancreatic β-cells.
Braun M
Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
[TBL] [Abstract][Full Text] [Related]
8. Paracrine regulation of insulin secretion.
Huising MO
Diabetologia; 2020 Oct; 63(10):2057-2063. PubMed ID: 32894316
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets.
DiGruccio MR; Mawla AM; Donaldson CJ; Noguchi GM; Vaughan J; Cowing-Zitron C; van der Meulen T; Huising MO
Mol Metab; 2016 Jul; 5(7):449-458. PubMed ID: 27408771
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter control of islet hormone pulsatility.
Gylfe E; Tengholm A
Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():102-10. PubMed ID: 25200303
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of Urocortin 3 does not prevent functional maturation of beta cells.
Huang JL; Lee S; Hoek P; van der Meulen T; Van R; Huising MO
J Endocrinol; 2020 Jul; 246(1):69-78. PubMed ID: 32369775
[TBL] [Abstract][Full Text] [Related]
12. Paracrine regulation of glucagon secretion: the β/α/δ model.
Watts M; Ha J; Kimchi O; Sherman A
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E597-E611. PubMed ID: 26837808
[TBL] [Abstract][Full Text] [Related]
13. The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets.
Kelly C; Parke HG; McCluskey JT; Flatt PR; McClenaghan NH
Diabetes Metab Res Rev; 2010 Oct; 26(7):525-33. PubMed ID: 20718077
[TBL] [Abstract][Full Text] [Related]
14. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, β-cell dysfunction, and diabetes.
Peiris H; Raghupathi R; Jessup CF; Zanin MP; Mohanasundaram D; Mackenzie KD; Chataway T; Clarke JN; Brealey J; Coates PT; Pritchard MA; Keating DJ
Endocrinology; 2012 Nov; 153(11):5212-21. PubMed ID: 23011918
[TBL] [Abstract][Full Text] [Related]
16. Isolated mouse islets respond to glucose with an initial peak of glucagon release followed by pulses of insulin and somatostatin in antisynchrony with glucagon.
Hellman B; Salehi A; Grapengiesser E; Gylfe E
Biochem Biophys Res Commun; 2012 Jan; 417(4):1219-23. PubMed ID: 22227186
[TBL] [Abstract][Full Text] [Related]
17. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival.
Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
Mol Cell Endocrinol; 2016 Nov; 436():102-13. PubMed ID: 27465830
[TBL] [Abstract][Full Text] [Related]
18. A temporal study of somatostatin secretion and its inhibitory effect in genetically diabetic mice (C57BL/KsJ-db/db).
Basabe JC; Pivetta OH; de Bruno LF; Cresto JC; Aparicio NJ
Endocrinology; 1983 Dec; 113(6):1927-34. PubMed ID: 6139272
[TBL] [Abstract][Full Text] [Related]
19. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
Chu ZL; Jones RM; He H; Carroll C; Gutierrez V; Lucman A; Moloney M; Gao H; Mondala H; Bagnol D; Unett D; Liang Y; Demarest K; Semple G; Behan DP; Leonard J
Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
[TBL] [Abstract][Full Text] [Related]
20. In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.
Yang XF; Ren LW; Yang L; Deng CY; Li FR
Endocr J; 2017 Mar; 64(3):291-302. PubMed ID: 28100871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
